Starting September 2021, Sopharma Trading will be partner on the Bulgarian market of the world-famous manufacturer of sensors for continuous measurement of glucose Dexcom. This partnership combines the innovation and high quality of the California-based brand with the expert approach, experience, and confidence of Sopharma Trading in the need for easy access to a product important for the long-term health and high quality of life of patients with diabetes in Bulgaria.
“I am proud that Dexcom, a brand that combines innovation and quality, is joining Sopharma Trading’s portfolio of exclusive brands. It is important for us that the new partnership will add value to our customers. With this partnership, we combine Dexcom’s ambition to design and develop innovative products with Sopharma Trading’s mission to lead the evolution of the healthcare sector and help people live happier and more fulfilling lives. Working with one of the most innovative companies in the category of sensors for monitoring and controlling blood sugar worldwide is a pleasure and recognition of the experience and expertise of our team“, said Plamen Kolev, CEO Exclusive Portfolio of Sopharma Trading.
Dexcom’s history dates back to 1999 and from the very beginning, it has been one of the leaders in the production of medical devices for continuous glucose monitoring. The company’s mission is to address the needs of consumers to simplify and improve diabetes management around the world by constantly designing and developing innovative products that meet the needs of each patient. Over its 22-year history, Dexcom has built partnerships with leaders such as Novo Nordisk, Lilly, Tandem Diabetes Care, Ypsomed, etc. to develop new diabetes control platforms and integrations to support more personalized and convenient treatment options. Today, Dexcom products are present in over 70 countries worldwide and are also used as hospital diagnostic devices.
More information about Dexcom can be found on the live webcast on 29.09.2021